// App-Quantinova.ai

6074 : A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.

Researchers

Presenter

  • Shuchi Gulati

Principal Investigators

  • Benyamin Yaniv

  • Sarah Palackdharry

  • Vinita Takiar

  • Michelle Lynn Mierzwa

  • Muhammad Kashif Riaz

  • John Charles Morris

  • Changchun Xie

  • J. Silvio Gutkind

  • Pankaj B Desai

  • Nooshin Hashemi Sadraei

  • Trisha Michel Wise-Draper

Medical Centers

  • University of Cincinatti Medical Center, Cincinatti, OH

  • University of Cincinnati, Cincinnati, OH

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Cincinnati Cancer Institute, Cincinnati, OH

  • UCSD, San Diego, CA

  • University of Cincinnati, College of Pharmacy, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Metformin Hydrochloride

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT02325401

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved